德国CellGenix  
CellGenix 公司成立于 1994 年，总部设在德国的海德堡。 是一家针对个体定制干细胞和肿瘤免疫疗法产品为时常导向的创新生物制药公司。重点开发、生产、和销售有效的用于癌症治疗及组织修复的细胞和蛋白创新产品。
主要特色产品：
CellGro 试剂盒系列 CellGro 干细胞生长培养基
CellGro 细胞因子 CellGro 树突状细胞生长培养基

CellGenix Technologie Transfer GmbH is an innovative biopharmaceutical company headquartered in Freiburg, Germany. CellGenix, which was founded in 1994 as a spin-off of the University Medical Center Freiburg, currently has more than 50 employees. CellGenix develops, manufactures and markets cell and protein therapeutics for cancer and orthopedic patients, as well as high-quality reagents for therapeutic ex vivo cell processing. The company owns Metreon Bioproducts GmbH, which was founded in 1996 and which is specialized on cell processing. CellGenix also owns shares in American Fluoroseal Cooperation (Afc) in Gaithersburg, Maryland (USA), and in CellPrep S.A. in Buenos Aires (Argentina).

CellGenix Main Building

View on GMP Facility block

R & D Labs
 

Innovative research and development

Serum-free Chondrocyte Culture
CellGenix's research focuses on stem cell therapy for the regeneration of tissues and organs, cancer immunotherapy and the development of GMP-grade ex vivo cell processing tools, like cytokines, serum-free media and closed kit systems. A patient-specific idiotype vaccine (IdioVax®) against Non-Hodgkin磗 B-cell lymphoma is already in a Phase II clinical trial which is being conducted in collaboration with Freiburg's University Medical Center and the Center for Clinical Research.

Cutting edge products and services

High Performance Cytokines
Together with its distribution partners CellGenix markets a variety of superior products and services for clinical cell therapy applications: cord blood cell processing and banking, autologous chondrocyte transplantation as well as GMP-grade cytokines, serum-free media and kit systems for ex vivo cell processing. Additionally, we offer specialized contract manufacturing services.
 

Safety and superior quality

Quality Control
CellGenix's extensive experience has enabled the company to build up a strong portfolio of products in the field of GMP-compliant production of cell and protein therapeutics. Continuous interaction with various competent authorities assures compliance with highest quality standards in the fields of individual biopharmaceuticals and cell based medicinal products. Since the Fall 2001, with the expansion of its office and production complex near the Freiburg airport, CellGenix has at its disposal one of the most technologically advanced GMP facilities for the processing and manufacturing of individual cell and protein therapeutics.